- Pedro Alonso, Scientifi c Director, Manhica Health Centre,
Manhica, Mozambique and Head, Center for International
Health, University of Barcelona, Spain
- Bill Antholis, German Marshall Fund U.S.
- John Audley, German Marshall Fund U.S.
- Ripley Ballou, Clinical R&D, GlaxoSmithKline Biologicals,
Rixensart, Belgium
- Luis Barreto, Aventis-Pasteur
- Carolyn Bartholomew, then Chief of Staff for Congresswoman
Nancy Pelosi
- Simon Best, Ardana
- Alan Brooks, Program for Accessible Technologies in
Health
- Graham Brown, Department of Medicine, University of Melbourne,
Australia
- Josh Buger, Vertex
- Chip Cale, GSK Biologicals
- Sandra Chang, Tropical Medicine and Medical Microbiology,
University of Hawaii
- Rob Chess, Nectar Therapeutics
- Chris Collins, Joint United Nations Programme on HIV/
AIDS
- Tim Cooke, Mojave Therapeutics
- Martinho Dgedge, Expanded Program on Immunization
Manager, Mozambique
- Carter Diggs, Senior Technical Advisor, U.S. Agency for International
Development
- Steve Drew, GSK Biologicals
- Laura Efros, Merck Vaccine Division
- Thomas Egwang, MedBiotech Laboratories, Uganda
- Ibrahim El Hassan, Institute of Endemic Diseases, University
of Khartoum, Sudan
- Howard Engers, Armauer Hansen Research Institute, Ethiopia
- Elaine Esber, Merck Vaccine Division
- Sarah Ewart , Malaria Vaccine Initiative
- Andrew Farlow, University of Oxford
- David Fleming, then Centers for Disease Control and Prevention;
now Bill & Melinda Gates Foundation
- Michael Fleming, Merck Vaccine Division
- Martin Friede, Initiative for Vaccine Research, World Health
Organization
- Joel Friedman, Center for Budget Policy and Priorities
- Geno Germano, Wyeth
- Roger Glass, Centers for Disease Control and Prevention
- Michel Greco, formerly Aventis
- Shanelle Hall, United Nations Childrenfs Fund, Supply Division
- Jane Haycock, U.K. Department for International
Development
- Rob Hecht, then World Bank, now International AIDS Vaccine
Initiative
- Russell Howard, Maxygen
- Suresh Jadhav, Serum Institute
- Stephen Jarrett, United Nations Childrenfs Fund, Supply Division
- Soren Jepsen, European Malaria Vaccine Initiative, Copenhagen,
Denmark
|
- Miloud Kaddar, World Health Organization
- Cheikh Kane, J P Morgan
- Hannah Kettler, Bill & Melinda Gates Foundation
- Marie-Paule Kieny, Director, Initiative for Vaccine Research,
World Health Organization
- Wenceslaus Kilama, African Malaria Vaccine Testing Network,
Tanzania
- Fred Kironde, Makerere University, Kampala, Uganda
- Andrew Kitua, Director General, National Institute for Medical
Research, Tanzania
- Richard Kogan, Center for Budget Policy and Priorities
- Antoniana Krettli, Fiocruz, Brazil
- James Kublin, Merck Vaccine Division
- Steve Landry, Bill & Melinda Gates Foundation
- Odile Leroy, Clinical and Regulatory Affairs, European
Malaria Vaccine Initiative
- Orin Levine, Pneumococcal Accelerated Development and
Introduction Plan
- Clem Lewin, Chiron
- Adel Mahmoud, Merck Vaccine Division
- Frank Malinoski, Wyeth
- Kevin Marsh, Kenya Medical Research Institute, Kilifi , Kenya
- Sean McElligot, Merck Vaccine Division
- Eunice Miranda, GSK Biologicals
- Marge Mitchell, Merck Vaccine Division
- Melinda Moree. Malaria Vaccine Initiative
- Debbie Myers, GSK Biologicals
- Angeline Nanni, Pneumococcal ADIP
- Thomas Netzer, Merck Vaccine Division
- Tim Obara, Merck Vaccine Division
- Paul Offi t, Childrensf Hospital of Philadelphia
- Stewart Parker, Targeted Genetics
- Jerry Parrot, Human Genome Sciences
- Alix Peterson Zwane, University of California, Berkeley
- Gina Rabinovich, Bill & Melinda Gates Foundation
- Patricia Roberts, Malaria Vaccine Initiative
- Una Ryan, Avant Theraputics Inc
- Jerry Sadoff, Aeras Global TB Vaccine Foundation
- Mark Sanyour, Merck Vaccine Division
- Andrew Segal, Genitrix
- Alan Shaw, Merck Vaccine Division
- Tim Sullivan, Princeton University Press
- Larry Summers, Harvard University
- Jim Tartaglia, Aventis-Pasteur
- Jean Tirole, Institut dfEconomie Industrielle
- Thomas Vernon, Merck Vaccine Division
- John Wecker, Rotavirus ADIP
- Lowell Weiss, Bill & Melinda Gates Foundation
- Roy Widdus, Institute for Public Private Partnerships in
Health
- Michel Zaffran, World Health Organization
|
